Cortagen
guinea pig4 sources
The rat data is the most interesting of any bioregulator after epitalon: measurable nerve regeneration and conduction recovery in a severed sciatic nerve model. But a severed rat sciatic nerve is not your brain, and no one has tested cortagen in a human for anything. If cognitive support is the goal, sleep, exercise, and a neurologist for anything real are where the evidence actually lives. Substituting cortagen for Cortexin, the crude brain extract with actual clinical history, has no clinical basis either.
What it is
A synthetic tetrapeptide derived from amino acid analysis of Cortexin, a crude brain-cortex peptide extract that has actual clinical use in Russian neurology. Cortagen is the short-peptide distillation of that extract: four amino acids meant to carry the signal without the complexity. The Khavinson bioregulator program’s theory is that these minimal peptides can reach their target tissue and normalize function, and cortagen’s target is the central nervous system.
In rats, cortagen stimulated nerve fiber regrowth, improved recovery from brain ischemia, and reduced oxidative damage. Among the Khavinson family, only epitalon has more published work behind it.
What the research shows
Rat neurology and one human-tissue lab study. No clinical trial:
Realistic protocols
No published study supports a human dose, route, or schedule for cortagen. The community runs the Khavinson bioregulator course: short subcutaneous runs of 10 to 20 days, sometimes stacked with other organ-specific bioregulators. Some people choose cortagen specifically when Cortexin is unavailable, treating the tetrapeptide as a cleaner stand-in for the crude extract. That substitution has no clinical basis. If you run it, keep the course short and do not assume that rat nerve data means cortagen does anything useful for a healthy human brain.
Side effects
No human safety data exists:
Where to buy
No live listings from tracked vendors right now.